HanAll Biopharma Appoints Christopher W. Slavinsky as Chief Business Development and Legal Officer
Position
Chief Business Development and Legal Officer
Company
HanAll Biopharma
SeoulBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
HanAll Biopharma has announced the appointment of Christopher W. Slavinsky to the position of Chief Business Development and Legal Officer. Christopher is expected to bring his extensive expertise in legal and business strategy to drive transformative initiatives and navigate complex regulatory landscapes for the company.
Quick answer
HanAll Biopharma Appoints Christopher W. Slavinsky as Chief Business Development and Legal Officer (July 15, 2024). HanAll Biopharma is based in Seoul, Seoul, South Korea.
- Who is the new Chief Business Development and Legal Officer at HanAll Biopharma?
- HanAll Biopharma named Christopher W. Slavinsky Chief Business Development and Legal Officer, announced July 15, 2024.
- What did HanAll Biopharma announce on July 15, 2024?
- HanAll Biopharma has announced the appointment of Christopher W. Slavinsky to the position of Chief Business Development and Legal Officer. Christopher is expected to bring his extensive expertise in legal and business strategy to drive transformative initiatives and navigate complex regulatory landscapes for the company.
- What does HanAll Biopharma do?
- HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with a presence in Korea, the USA, Japan, and Indonesia, with a mission to make meaningful contributions to patients' lives by introducing...
- Where is HanAll Biopharma based?
- HanAll Biopharma is based in Seoul, Seoul, South Korea.
- Which similar companies made leadership changes around the same time?
- Alkeus Pharmaceuticals (July 16, 2024), NS Pharma (July 10, 2024), AbbVie Inc. (July 10, 2024) and Jazz Pharmaceuticals plc (July 9, 2024) also announced leadership changes within 45 days of HanAll Biopharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer (July 16, 2024)
- NS Pharma, Inc. Appoints Yukiteru Sugiyama as President at Its US Headquarters (July 10, 2024)
- AbbVie Appoints Roopal Thakkar, M.D. as Executive Vice President, R&D and Chief Scientific Officer (July 10, 2024)
- Jazz Pharmaceuticals promotes Samantha Pearce to Chief Commercial Officer (July 9, 2024)
- Pfizer Initiates Search for Successor to Dr. Mikael Dolsten as Chief Scientific Officer (July 9, 2024)
- CASI Pharmaceuticals Appoints Daniel Lang, MD as Chief Financial Officer and Senior Vice President (July 8, 2024)
Who to call at HanAll Biopharma, and when
A new leader at HanAll Biopharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day HanAll Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HanAll Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HanAll Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HanAll Biopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
HanAll Biopharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.